IRIS
DURANTI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.505
EU - Europa 9.449
AS - Asia 5.802
SA - Sud America 495
AF - Africa 71
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 10
Totale 30.369
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.331
CN - Cina 2.798
GB - Regno Unito 2.615
IT - Italia 2.016
SG - Singapore 1.655
UA - Ucraina 1.375
SE - Svezia 709
RU - Federazione Russa 677
FI - Finlandia 553
TR - Turchia 499
DE - Germania 465
BR - Brasile 375
FR - Francia 351
IE - Irlanda 332
VN - Vietnam 315
IN - India 142
CA - Canada 109
PL - Polonia 84
NL - Olanda 73
JP - Giappone 62
KR - Corea 58
HK - Hong Kong 56
ES - Italia 43
BD - Bangladesh 42
AR - Argentina 40
MX - Messico 40
AU - Australia 30
AT - Austria 27
BE - Belgio 26
IQ - Iraq 26
ZA - Sudafrica 26
ID - Indonesia 22
CL - Cile 19
IR - Iran 14
PK - Pakistan 14
CO - Colombia 13
AE - Emirati Arabi Uniti 12
EC - Ecuador 11
LT - Lituania 11
SA - Arabia Saudita 11
CH - Svizzera 10
PE - Perù 10
UZ - Uzbekistan 10
VE - Venezuela 10
MA - Marocco 9
HR - Croazia 8
HU - Ungheria 8
JO - Giordania 8
PY - Paraguay 8
RO - Romania 8
EU - Europa 7
LV - Lettonia 7
MY - Malesia 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
BG - Bulgaria 6
GR - Grecia 6
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
PH - Filippine 6
TN - Tunisia 6
CR - Costa Rica 5
EG - Egitto 5
SM - San Marino 5
TH - Thailandia 5
TW - Taiwan 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DZ - Algeria 4
KG - Kirghizistan 4
UY - Uruguay 4
AM - Armenia 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LU - Lussemburgo 3
NG - Nigeria 3
NO - Norvegia 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
Totale 30.345
Salva come PNG Salva come JPEG
Città #
Southend 2.316
Woodbridge 1.678
Ann Arbor 1.244
Houston 1.125
Jacksonville 1.092
Ashburn 1.072
Fairfield 1.052
Chandler 894
Singapore 857
San Jose 822
Nanjing 557
Dallas 481
Cambridge 476
Wilmington 449
Seattle 436
Beijing 415
Izmir 345
Boardman 282
Dublin 271
Urbino 249
Helsinki 236
Council Bluffs 205
Nanchang 192
New York 178
San Mateo 169
Lauterbourg 165
Princeton 161
Los Angeles 131
Hebei 118
Shenyang 118
Changsha 98
Jiaxing 97
Ho Chi Minh City 96
Istanbul 92
Tianjin 87
Velikiy Novgorod 82
Santa Clara 71
Milan 69
Düsseldorf 67
Hanoi 66
Rome 64
Buffalo 63
Munich 59
Kunming 57
Hong Kong 54
San Francisco 53
Seongnam 52
Toronto 50
Menlo Park 48
Moscow 48
London 47
San Diego 47
São Paulo 47
Dong Ket 46
Bremen 43
Shanghai 42
Nuremberg 38
Guangzhou 35
Hangzhou 35
Warsaw 35
Frankfurt am Main 34
Stockholm 34
Chicago 33
Jinan 33
Mülheim 32
Denver 31
Des Moines 31
Kraków 30
Orem 30
Changchun 28
Tokyo 28
Brussels 24
Chennai 24
Montreal 24
Mumbai 24
Ningbo 23
Lanzhou 22
Ancona 20
Brooklyn 20
Manchester 20
Palermo 20
The Dalles 20
Napoli 19
Amsterdam 18
Dearborn 18
Norwalk 18
Zhengzhou 18
Haikou 17
Leawood 17
Mexico City 17
Phoenix 17
Taizhou 17
Hefei 16
Johannesburg 16
Naples 16
Pesaro 16
Shenzhen 16
Ankara 15
Cava De' Tirreni 15
Florence 15
Totale 20.460
Salva come PNG Salva come JPEG
Nome #
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 879
Derivatizzazione one-pot di indoli per la sintesi di triptofani, pirroloindoline, bis-indoli & co 464
Unsaturated fatty acids lactose esters: cytotoxicity, permeability enhancement and antimicrobial activity 418
Pharmacokinetics, pharmacodynamics and safety studies on URB 937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats 372
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 352
A New Synthesis of 2-Substituted DL-Tryptophan Derivatives 289
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 288
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 286
Antitumoral activity of indole-3-carbinol cyclic tri- and tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies 286
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis, Binding Affinity for Melatonin Receptor, and Evaluation of the Biological Activity 285
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 284
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 269
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 267
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus 265
Lactose oleate as new biocompatible surfactant for pharmaceutical applications 261
The Synthetic Cannabinoid URB447 Reduces Brain Injury and the Associated White Matter Demyelination After Hypoxia-Ischemia in Neonatal Rats 260
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 257
A combination of sugar esters and chitosan to promote in vivo wound care 255
Synthesis, Structure-Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability Enhancers 253
Synthesis and Evaluation of Saccharide-Based Aliphatic and Aromatic Esters as Antimicrobial and Antibiofilm Agents 247
2-Bromomelatonin: Synthesis and characterization of a potent melatonin agonist 246
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 246
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 243
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 243
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 239
Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines 235
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 235
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 233
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 233
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats 227
A practical and expeditious method for the preparation of the anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 225
An endocannabinoid mechanism for stress-induced analgesia 222
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 219
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 217
Peripherally Restricted FAAH Inhibitors 216
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 215
Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanyl Carbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors 215
A Versatile Biomimetic Approach to Diindolylmethane Derivatives as Potential Anticancer Agents 213
The indole-3-carbinol tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines 213
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 211
Indole-3-carbinol (I3C) Tetrameric Derivative (CTet) Inhibits Cell Cycle Progression Inducing Overexpression of p21/cip1/waf1 and GADD45A in Breast Cancer Cell Lines 211
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 209
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis and Binding Affinity to the Melatonin Receptor 206
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 206
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 204
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 203
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 201
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 201
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 196
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 194
N-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis, Structure–Activity and Structure–Property Relationships 194
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 193
Antimyotonic effects of enantiomers of mexiletine-like drugs 193
Modulation of anxiety through blockade of anandamide hydrolysis 193
Therapeutic Effects of Tocainide and Mexiletine Analogs on Myotonic MTO and ADR Mice 192
Synthesis and Structure–Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors 191
Derivato tetramerico ciclico dell’indol-3-carbinolo CTet come chemiopreventivo in tumori al seno estrogeno-dipendenti 191
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 188
α-Acylamino-β-lactones as a new class of N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitors: synthesis and structure–activity relationships 187
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice 186
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 186
SYNTHESIS AND EVALUATION OF SUGAR-BASED ALIPHATIC AND AROMATIC FATTY ACID ESTERS AS ANTIMICROBIAL AND ANTIBIOFILM AGENTS 186
Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring 185
Synthesis and Structure–Activity Relationship Studies of O-Biphenyl-3-yl Carbamates as Peripherally Restricted Fatty Acid Amide Hydrolase Inhibitors 185
Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition 184
Synthesis and Structure-Activity/Stability Relationships of Carbamate Inhibitors of the FAAH Enzyme 183
The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues 183
Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597) 182
The CB1 Antagonist/CB2 Agonist URB447 Confers Neuroprotection after Neonatal Hypoxia-ischemia 182
N-alchil-O-arilcarbammati come inibitori delle idrolasi delle ammidi degli acidi grassi (FAAH): aspetti meccanicistici 179
Sintesi e studi di relazione struttura–attività/selettività su O-bifenil-3-ilcarbammati disostituiti quali inibitori periferici dell’enzima FAAH 179
The collisional behavior of ESI-generated protonated molecules of some carbamate FAAH inhibitors isosteres and its relationships with biological activity 179
Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels 177
Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors 176
A linear relationship between MS/MS data and FAAH inhibitory activity of some carbamates 174
Identification of a Bioactive Impurity Present in a Sample of URB754 173
Selective inhibition of 2 - AG hydrolysis enhances endocannabinoid signaling in the hippocampus 171
Analoghi chirali della mexiletina: attività sui canali ionici 168
3D-QSAR study of carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 165
Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3'-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation 163
Stereospecific synthesis of mexiletine and related compounds: Mitsunobu versus Williamson reaction 159
Synthesis and Biological Characterization of the New Glycolipid Lactose Undecylenate (URB1418) 158
Design, SAR and Biological Activity of a New Class of FAAH Inhibitors: Cyclohexyl Carbamic Acid Biphenyl-3-yl Esters 157
Synthesis and pharmacological characterization of URB447, a new cannabinoid receptor neutral antagonist 157
2,6-Xilididi e β-2,6-xililossietilammine come ligandi anfipatici per i recettori benzodiazepinici di tipo mitocondriale 157
Antinociceptive effects of the brain-impermeant fatty-acid amide hydrolase inhibitor URB937 156
Contribution to the Study of 2-Aryloxy-1-phenyl and 2-Aryloxy-2-phenylethanols. Differentiation by Mass Spectrometry 155
Antinoceptive Effects of the N-Acylethanolamine Acid Amidase Inhibitor ARN077 in Rodent Pain Models 154
Tandem mass spectrometric data–FAAH inhibitors activity relationships of some carbamic acid O-aryl esters 152
Inhibitors of lysosomal lipid amidase NAAA 152
Relationships Between Mass Spectrometry and Biological Stability of Some N-Acylethanolamine Acid Amidase Inhibitors 152
Anestetici locali (Cap. 14) 151
Chronic stimulation of the endogenous anandamide tone reduces cocaine-seeking and cue-induced relapse in rats 149
QSAR and molecular modelling investigations of a new series of alkyl carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 146
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 145
URB602, a Monoacylglycerol Lipase Inhibitor, Protects from the Long-term Consequences of a Neonatal Hypoxic-ischemic Brain Injury in Rats 145
Structure-Activity Relationships of Alkylcarbamic Acid Aryl Esters, as Fatty Acid Amide Hydrolase Inhibitors 145
Design, Synthesis and SAR of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acids Amide Hydrolase Inhibitors 145
Synthesis and Biological Evaluation of 6-O-Sucrose Monoester Glycolipids as Possible New Antifungal Agents 145
FAAH and MGL Inhibitors. Design and Therapeutic Implications 143
Totale 21.605
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 0 0 159
2021/20221.758 89 219 205 183 71 41 83 97 121 99 47 503
2022/20232.761 312 129 65 357 215 574 42 241 467 93 149 117
2023/2024781 96 54 56 91 54 166 37 49 15 66 28 69
2024/20252.662 139 140 619 204 97 192 296 152 244 160 237 182
2025/20266.658 538 724 779 1.069 508 457 868 264 446 533 352 120
Totale 30.638